Home Cart 0 Sign in  
X

[ CAS No. 50893-53-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 50893-53-3
Chemical Structure| 50893-53-3
Chemical Structure| 50893-53-3
Structure of 50893-53-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 50893-53-3 ]

Related Doc. of [ 50893-53-3 ]

Alternatived Products of [ 50893-53-3 ]

Product Details of [ 50893-53-3 ]

CAS No. :50893-53-3 MDL No. :MFCD00000647
Formula : C3H4Cl2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :QOPVNWQGBQYBBP-UHFFFAOYSA-N
M.W : 142.97 Pubchem ID :521305
Synonyms :

Calculated chemistry of [ 50893-53-3 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.67
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 27.8
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.54 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.73
Log Po/w (XLOGP3) : 2.3
Log Po/w (WLOGP) : 1.95
Log Po/w (MLOGP) : 0.89
Log Po/w (SILICOS-IT) : 1.17
Consensus Log Po/w : 1.61

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.04
Solubility : 1.29 mg/ml ; 0.00905 mol/l
Class : Soluble
Log S (Ali) : -2.49
Solubility : 0.462 mg/ml ; 0.00323 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.21
Solubility : 8.77 mg/ml ; 0.0614 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.07

Safety of [ 50893-53-3 ]

Signal Word:Danger Class:6.1,3,8
Precautionary Statements:P501-P270-P262-P202-P240-P210-P233-P201-P243-P241-P242-P264-P280-P370+P378-P308+P313-P361+P364-P303+P361+P353-P301+P330+P331-P301+P312+P330-P304+P340+P310-P305+P351+P338+P310-P403+P235-P405 UN#:2742
Hazard Statements:H310-H302-H314-H341-H226 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 50893-53-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 50893-53-3 ]
  • Downstream synthetic route of [ 50893-53-3 ]

[ 50893-53-3 ] Synthesis Path-Upstream   1~28

  • 1
  • [ 50893-53-3 ]
  • [ 100-39-0 ]
  • [ 28957-72-4 ]
YieldReaction ConditionsOperation in experiment
44% With triethylamine In tetrahydrofuran; methanol; ethyl acetate; 1,2-dichloro-ethane 8-Benzyl-8-Aza-Bicyclo[3.2.1]Octan-3-One
To a stirred solution of 29.2 g (209 mmol) tropinone in 300 mL 1,2-dichloroethane was added 45.5 mL (419 mmol) 1-chloroethyl chloroformate, and the resulting solution was warmed to 80° C.
The reaction was monitored by TLC on a SiO2 plate eluding with EtOAc/2M NH3:MeOH (5:1).
After stirring for 18 h, the solvent was evaporated, 300 mL MeOH was added, and the reaction was heated to reflux.
After 45 min, the solvent was evaporated, then 300 mL THF, 38.83 g (227 mmol) benzyl bromide, and 33 mL (24.0 g, 237 mmol) triethylamine was added, and the resulting mixture was stirred at 23° C.
After 69 h, the mixture was transferred to a separatory funnel containing 200 mL sat. NaHCO3 solution.
The aqueous layer was extracted with EtOAc (2*300 mL), then the combined organics were washed with water (100 mL), brine (100 mL), dried over MgSO4 filtered and evaporated to a brown oil.
The crude material was purified by flash chromatography on SiO2, using a gradient elution of CH2Cl2/ EtOAc (40:1 to 20:1 to 8:1 to 4:1).
The appropriate fractions were combined and evaporated to afford 19.91 g (92 mmol, a 44percent yield) of the title compound as a yellow-orange oil. MS (ES) m/z: 216 (MH)+.
44% With triethylamine In tetrahydrofuran; methanol; ethyl acetate; 1,2-dichloro-ethane 8-Benzyl-8-aza-bicyclo[3.2.1]octan-3-one
To a stirred solution of 29.2 g (209 mmole) tropinone in 300 mL of 1,2-dichloroethane was added 45.5 mL (419 mmole) 1-chloroethyl chloroformate, and the resulting solution was warmed to 80° C.
The reaction was monitored by thin layer chromatography on a silica gel plate eluding with EtOAc/2M NH3:MeOH (5:1).
After stirring for 18 h, the solvent was evaporated, 300 mL MeOH was added, and the reaction was heated to reflux.
After 45 min, the solvent was evaporated, then 300 mL THF, 38.83 g (227 mmol) benzyl bromide, and 33 mL (24.0 g, 237 mmol) triethylamine was added, and the resulting mixture was stirred at 23° C.
After 69 h, the mixture was transferred to a separatory funnel containing 200 mL sat. NaHCO3 solution.
The aqueous layer was extracted with EtOAc (2*300 mL), then the combined organics were washed with water (100 mL), brine (100 mL), dried over MgSO4 filtered and evaporated to a brown oil.
The crude material was purified by flash chromatography on SiO2, using a gradient elution of CH2Cl2/ EtOAc (40:1 to 20:1 to 8:1 to 4:1).
The appropriate fractions were combined and evaporated to afford 19.91 g (92 mmol, a 44percent yield) of the title compound as a yellow-orange oil. MS (ES) m/z: 216 (MH)+.
Reference: [1] Patent: US2003/32648, 2003, A1,
[2] Patent: US2002/183322, 2002, A1,
  • 2
  • [ 50893-53-3 ]
  • [ 627-30-5 ]
  • [ 6940-76-7 ]
Reference: [1] Tetrahedron Letters, 1985, vol. 26, # 44, p. 5445 - 5446
  • 3
  • [ 541-41-3 ]
  • [ 50893-53-3 ]
YieldReaction ConditionsOperation in experiment
24% Reflux To a solution of ethyl chloroformate (11.35 g, 104.6 mmol, 1.0 eq) and sulfuryl chloride (15.38 g, 114.0 mmol, 1.09 eq) benzoyl peroxide (0.034 g, 0.14 mmol, 0.001 eq) was added and the reaction mixture was refluxed for overnight and it was distilled at atmospheric pressure (boiling range 119-140 °C) to give 1-chloroethyl chloroformate (3.5 g, 24percent yield) as colorless liquid. 1H NMR (300 MHz, CDCl3): δ ppm 6.45 (q, 1H, J= 5.7 Hz), 1.88 (d, 3H, J= 5.7 Hz).
Reference: [1] Patent: WO2013/160810, 2013, A2, . Location in patent: Paragraph 0167
[2] Justus Liebigs Annalen der Chemie, 1890, vol. 258, p. 51,61
[3] Farmaco, 2003, vol. 58, # 5, p. 363 - 369
[4] Patent: US5310929, 1994, A,
[5] Patent: US4611056, 1986, A,
[6] Patent: US4666907, 1987, A,
[7] Patent: US4755598, 1988, A,
[8] Patent: EP138481, 1991, B1,
  • 4
  • [ 75-44-5 ]
  • [ 75-07-0 ]
  • [ 50893-53-3 ]
Reference: [1] Journal of Organic Chemistry, 1984, vol. 49, # 11, p. 2081 - 2082
[2] Patent: US4592872, 1986, A,
[3] Bulletin of the Academy of Sciences of the USSR, Division of Chemical Science (English Translation), 1991, vol. 40, # 11.1, p. 2185 - 2189[4] Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1991, # 11, p. 2508 - 2512
  • 5
  • [ 75-07-0 ]
  • [ 503-38-8 ]
  • [ 50893-53-3 ]
Reference: [1] Patent: US4614829, 1986, A,
  • 6
  • [ 32315-10-9 ]
  • [ 75-07-0 ]
  • [ 50893-53-3 ]
Reference: [1] Patent: WO2006/63578, 2006, A2, . Location in patent: Page/Page column 24
[2] Synthetic Communications, 2003, vol. 33, # 12, p. 2045 - 2052
[3] Journal of Medicinal Chemistry, 2014, vol. 57, # 13, p. 5748 - 5763
  • 7
  • [ 75-07-0 ]
  • [ 503-38-8 ]
  • [ 50893-53-3 ]
Reference: [1] Patent: US4614829, 1986, A,
  • 8
  • [ 56-23-5 ]
  • [ 64-17-5 ]
  • [ 105-57-7 ]
  • [ 75-44-5 ]
  • [ 67-66-3 ]
  • [ 67-72-1 ]
  • [ 50893-53-3 ]
  • [ 541-41-3 ]
  • [ 75-07-0 ]
  • [ 141-78-6 ]
  • [ 105-58-8 ]
Reference: [1] Journal of Catalysis, 2010, vol. 275, # 2, p. 243 - 249
  • 9
  • [ 124-05-0 ]
  • [ 75-34-3 ]
  • [ 5130-24-5 ]
  • [ 50893-53-3 ]
  • [ 627-11-2 ]
Reference: [1] Patent: US2377085, 1943, ,
  • 10
  • [ 64-17-5 ]
  • [ 50893-53-3 ]
  • [ 50893-36-2 ]
YieldReaction ConditionsOperation in experiment
78.5 g at 0 - 20℃; for 0.3 h; In the cooling to 0 °C under the 71.5 g (0.5 μM) 1 - chloro ethyl formate ester drop to 40 g and 52.0 g triethylamine 250 ml in toluene solution, about 2 hr after the completion of the dropping, then the temperature to room Temperature the reaction system, the reaction 1 hr, filtered to remove the solid, distilling and getting the intermediate H - 1 is 78.5 g.
Reference: [1] Synthesis, 1986, # 8, p. 627 - 632
[2] Patent: EP1437352, 2004, A1, . Location in patent: Page 17
[3] Journal of Medicinal Chemistry, 2014, vol. 57, # 13, p. 5748 - 5763
[4] Patent: WO2016/207216, 2016, A1, . Location in patent: Page/Page column 70
[5] Patent: CN107652239, 2018, A, . Location in patent: Paragraph 0098
[6] Tetrahedron Letters, 2016, vol. 57, # 14, p. 1619 - 1621
[7] Patent: CN108570008, 2018, A, . Location in patent: Paragraph 0228; 0229; 0230
  • 11
  • [ 50893-53-3 ]
  • [ 50893-36-2 ]
Reference: [1] Patent: US5674468, 1997, A,
[2] Patent: US4426391, 1984, A,
  • 12
  • [ 17012-21-4 ]
  • [ 50893-53-3 ]
  • [ 24424-99-5 ]
  • [ 122684-33-7 ]
Reference: [1] Patent: US2003/229226, 2003, A1, . Location in patent: Page 16-17
  • 13
  • [ 50893-53-3 ]
  • [ 6760-99-2 ]
Reference: [1] Patent: US6187777, 2001, B1,
[2] Patent: US2003/60494, 2003, A1,
  • 14
  • [ 529-17-9 ]
  • [ 50893-53-3 ]
  • [ 6760-99-2 ]
Reference: [1] Patent: EP1258480, 2002, A1, . Location in patent: Page 34-35
  • 15
  • [ 50893-53-3 ]
  • [ 532-24-1 ]
  • [ 25602-68-0 ]
Reference: [1] Patent: WO2004/100946, 2004, A1, . Location in patent: Page 77
  • 16
  • [ 50893-53-3 ]
  • [ 67-63-0 ]
  • [ 98298-66-9 ]
YieldReaction ConditionsOperation in experiment
99% at -78 - 25℃; a solution of 2-propanol (0.64 mL, 8.39 mmol) and pyridine (0.79 mL, 9.79 mmol) at -78°C was added 1-chloroethyl chlorofonnate (0.76 mL, 6.99 mmol) dropwise. The reaction mixture was allowed to slowly warm to room temperature and stir overnight. The reaction mixture became a solid white clump and was sonicated in dichloromethane. The resulting suspension was concentrated and the white solid was dissolved in ethyl acetate and washed with water and brine. The organics were dried over magnesium sulfate, filtered and concentrated to afford the title compound as a colorless liquid, 1.29 g, 99percent.‘H NMR (300 MHz, CDCl3 ö: 1.35 (m, 6H); 1.84 (d, 3H); 4.96 (m, 1H); 4.44 (m, 1H).
97% With pyridine In dichloromethane at -78 - 20℃; PREPARATION 46; 1-Chloroethyl isopropyl carbonate; To a solution of isopropanol (1.09 g, 18.27 mmol) and pyridine (1.45 g, 18.35 mmol) in of dichloromethane (30 ml) at-78 °C was dropwise added (10 minutes) 1-chloroethyl chloroformate (2.66 g, 18.60 mmol) under argon. After the addition, the cooling bath was removed and the mixture was allowed to warm to rt and stirred at that temperature overnight. The reaction was diluted with additional dichloromethane (20 ml), washed with brine and dried over anhydrous sodium sulfate. Removal of the solvent under reduced pressure afforded the title compound as a colourless oil (3 g, 97percent yield). No. (CDCl3): 1.33 (d, 3H), 1.35 (d, 3H), 1.84 (d, 3H), 4.95 (m, 1H), 6.43 (q, 1H).
87.7% With pyridine In diethyl ether at 0 - 20℃; 0.66 g of isopropanol was added to 1.43 g of 1-chloroethyl chloroformate, and the solution was cooled to 0° C. in an ice-water bath. The mixture of 0.84 g of pyridine and 10 ml ethyl ether was added dropwise into the solution. The solution was reacted for 1 hour at that temperature, following 4 hours at room temperature. The reaction was stopped and the mixture was filtered, and the filtrate was washed respectively with 10percent hydrochloric acid and water once. The organic phase was dried and concentrated to give 1.461 g of a light yellow liquid 1-chloroethyl isopropyl carbonate with a yield of 87.7percent. The crude was directly used in the next reaction without purification.
81%
Stage #1: at 0℃; for 0.25 h;
Stage #2: With pyridine In dichloromethane at 20℃;
The compound 1-chloroethyl chloroformate (3 ml, 27.8 mmol) was diluted with DCM (25 ml)Cooled to 0 ° C,Isopropanol (2.1 ml, 27.8 mmol) diluted with DCM (25 ml) was slowly added with a constant pressure dropping funnel,Reaction about 15min,Pyridine (2.4 ml, 30.6 mmol) diluted with DCM (5 ml) was added slowly using a constant pressure dropping funnel,The process to keep the same low temperature,After adding,Reaction at room temperature overnight,Then diluted with water,Extracted with DCM,Organic phase dry,After concentration of 3.74g light yellow liquid,The yield was 81percent.
68% With pyridine In dichloromethane at 0 - 20℃; for 0.75 h; Preparation Example 1 : Preparation of 1 -iodoethyl isopropylcarbonate(1) ; Preparation of 1-chloroethyl isopropylcarbonate 1-Chloroethyl chloroformate (31.7 g, 0.22 mol) was dissolved in methylene chloride (200 ml), and isopropanol (39.7 ml, 0.52 mol) was added thereto while ice-cooling. Pyridine (23 ml, 0.28 mol) was slowly added to the reaction mixture over 15 minutes. The reaction mixture was slowly heated to room temperature and then stirred for 30 minutes. The reaction mixture was sequentially washed with water, 5percent brine, and 5percent potassium hydrogen sulfate solution, dried over anhydrous magnesium sulfate, and then filtered. The filtrate was distilled under a reduced pressure to obtain 25 g of 1-chloroethyl isopropylcarbonate (yield: 68percent). bpδδmmHg: 92-94 0C ; <n="19"/>1H-NMR(200MHz, CDCI3) δ 1.33(d, J=6.0Hz, 6H), 1.79(d, J=6.0Hz, 3H), 4.84(heptet, J=6.0Hz, 1 H), 6.37(q, J=6.0Hz, 1 H)
3.1 g With pyridine In dichloromethane at 0℃; for 0.666667 h; To a solution of 1-Chloroethyl chloroformate (step-1, 3.5 g, 24.4 mmol, 1.0 eq) in CH2C12 (40 ml) isopropanol (1.76 g, 29.3 mmol, 1.2 eq) was added at 0 °C then pyridine (1.25 g, 15.8 mmol, 0.65 eq) was added dropwise to the solution over a period of 10 minutes. Once the addition finished, the reaction mixture was stirred at the same temperature for 30 minutes. The reaction mixture was washed successively with water (2x30 ml), 5percent potassium hydrogen sulfate (2x30 ml) and brine solution (2x30 ml). The combined organic layers were dried over anhydrous sodium sulphate, filtered and evaporated under reduced pressure to obtain the title compound (3.1 g) as colorless liquid. 1H NMR (300 MHz, CDCl3): δ ppm 6.43 (q, 1H, J= 5.7 Hz), 5.0-4.89 (m, 1H), 1.83 (d, 3H, J= 5.7 Hz), 1.34 (d, 3H, J= 4.5 Hz), 1.32 (d, 3H, J= 4.5 Hz).

Reference: [1] Patent: WO2018/53215, 2018, A1, . Location in patent: Page/Page column 135
[2] Patent: WO2005/123693, 2005, A1, . Location in patent: Page/Page column 66
[3] Patent: US2009/36505, 2009, A1, . Location in patent: Page/Page column 11-12
[4] Patent: CN106467474, 2017, A, . Location in patent: Paragraph 0069; 0070; 0071; 0072
[5] Patent: WO2009/66917, 2009, A2, . Location in patent: Page/Page column 16-17
[6] Farmaco, 2003, vol. 58, # 5, p. 363 - 369
[7] Patent: EP1988090, 2008, A1, . Location in patent: Page/Page column 13-14
[8] Patent: EP1437352, 2004, A1, . Location in patent: Page 31
[9] Patent: WO2010/17418, 2010, A1, . Location in patent: Page/Page column 102; 116
[10] Patent: US2011/34434, 2011, A1, . Location in patent: Page/Page column 82; 93
[11] Patent: EP2447264, 2012, A1, . Location in patent: Page/Page column 161
[12] Patent: US2013/244958, 2013, A1, . Location in patent: Paragraph 0125
[13] Patent: WO2013/160810, 2013, A2, . Location in patent: Paragraph 0168
[14] Patent: WO2014/12074, 2014, A2, . Location in patent: Paragraph 00161; 00162
[15] Patent: US2014/56849, 2014, A1, . Location in patent: Paragraph 0459-0460
[16] Patent: WO2015/108835, 2015, A1, . Location in patent: Paragraph 00128
[17] Patent: CN107652239, 2018, A, . Location in patent: Paragraph 0045
[18] Patent: CN103626765, 2016, B, . Location in patent: Paragraph 0620; 0622; 0623
  • 17
  • [ 50893-53-3 ]
  • [ 98298-66-9 ]
Reference: [1] Patent: US4483867, 1984, A,
  • 18
  • [ 50893-53-3 ]
  • [ 108-93-0 ]
  • [ 99464-83-2 ]
YieldReaction ConditionsOperation in experiment
94% With pyridine In dichloromethane at 0 - 20℃; EXAMPLE 4
Synthesis of PGB-03 (3-Aminomethyl-5-methyl-hexanoic acid 1-cyclohexyloxycarbonyloxy-ethyl ester)
Procedure:
Cyclohexy alcohol (1.4 g, 13.97 mmol) was dissolved in CH2Cl2 (15 mL) under the treatment in a nitrogen atmosphere (0-5° C.).
1-Chloroethyl chloroformate (2.0 g, 13.97 mmol) and CH2Cl2 (10 mL) were slowly added.
The solution was stirred for 15 minutes and pyridine (1.22 g, 15.42 mmol) and CH2Cl2(2 mL) were added dropwise.
After stirring overnight at room temperature, CH2Cl2 (20 mL) and water (20 mL) were added to the reaction solution.
The product was extracted to the CH2Cl2 phase and washed with water (3*20 mL).
The residue was dried and concentrated to give 2.64 g of Carbonic acid cyclohexyl ester 1-chloro-ethyl ester 6 (Yield: 94percent).
1H-NMR (CDCl3, 500 MHz) δ 1.22-1.30 (m, 1H), 1.32-1.41 (m, 2H), 1.42-1.58 (m, 3H), 1.71-1.80 (m, 2H), 1.83 (d, J=6.0 Hz, 3H), 1.89-2.00 (m, 2H), 4.65-4.72 (m, 1H), 6.43 (q, J=6.0 Hz, 1H).
94% With pyridine In dichloromethane at 0 - 20℃; Inert atmosphere Cyclohexy alcohol (1.4 g, 13.97 mmol) was dissolved in CH2CI2 (15 mL) under the treatment in a nitrogen atmosphere (0 -5°C). 1-Chloroethyl chloroformate (2.0 g, 13.97 mmol) and CH2CI2 (10 mL) were slowly added. The solution was stirred for 15 minutes and pyridine (1.22g, 15.42 mmol) and CH2CI2 (2 mL) were added dropwise. After stirring overnight at room temperature, CH2CI2 (20 mL) and water (20 mL) were added to the <n="19"/>reaction solution. The product was extracted to the CH2CI2 phase and washed with water (3 x 20 ml_). The residue was dried and concentrated to give 2.64 g of Carbonic acid cyclohexyl ester 1-chloro-ethyl ester 6 (Yield: 94percent). 1HNMR(CDCI3, 500 MHz) δ 1.22-1.30(m, 1 H), 1.32-1.41 (m, 2H), 1.42-1.58(m, 3H), 1.71-1.80(m, 2H), 1.83(d, J=6.0 Hz, 3H), 1.89-2.00(m, 2H), 4.65-4.72(m, 1H), 6.43(q, J=6.0 Hz, 1H).
80% With pyridine In dichloromethane at -78℃; Cyclohexanol (0.50 g, 5.0 mmol) and pyridine (0.40 ml, 5.0 mmol) were dissolved in 10 ml dichloromethane and the mixture cooled to -78 ºC. a solution of 1-chloroethyl carbonochloridate (0.54 ml, 5.0 mmol) dissolved in 2 ml dichloromethane was added drop-wise and with stirring.
The mixture was stirred for 30 min at -78ºC and then overnight, warming to room temperature and forming a precipitate.
The mixture was diluted with dichloromethane and was washed sequentially with twice with water, once with 0.1N hydrochloric acid, once with water and once with brine.
The organics were dried over sodium sulphate, filtered and evaporated under reduced pressure to give 0.82 g (4.0 mmol, 80percent) of the title compound as a colourless oil.
1H NMR (400 MHz, CHLOROFORM-d) δ ppm 6.43 (1 H, q, J=5.9 Hz), 4.69 (0 H, tt, J=9.0, 4.5 Hz), 1.89 - 2.01 (2 H, m), 1.83 (3 H, d, J=5.9 Hz), 1.70 - 1.81 (2 H, m), 1.45 - 1.58 (2 H, m), 1.22 - 1.44 (4 H, m).
70% With pyridine In dichloromethane at 0 - 20℃; for 16.25 h; Preparation Example 2: ; Preparation of 1 -iodoethyl cyclohexylcarbonate(1) Preparation of 1-chloroethyl cyclohexylcarbonateCyclohexanol (19 ml, 0.18 mol) was dissolved in methylene chloride (300 ml), and pyridine (14.8 ml, 0.18 mol) was added thereto while ice-cooling. 1-Chloroethyl chloroformate (20 ml, 0.185 mol) was slowly added to the reaction mixture over 15 minutes. The reaction mixture was slowly heated to room temperature and then stirred for 16 hours. The reaction mixture was sequentially washed with water, brine, and 5percent sodium thiosulfate solution, dried over anhydrous magnesium, and then filtered. The filtrate was distilled under a reduced pressure to obtain 26.06 g of 1-chloroethyl cyclohexylcarbonate (yield: 70percent). <n="20"/>bpδδmmHg: 101 -103 °C ;1H-NMR(200MHz, CDCI3) δ 1.0-2.3(m, 10H), 1.38(d, J=5.8Hz, 3H), 4.60-4.80(m, 1 H), 6.40(q, J=5.8Hz, 1 H).

Reference: [1] Patent: US2008/125483, 2008, A1, . Location in patent: Page/Page column 6-7
[2] Patent: WO2009/118580, 2009, A2, . Location in patent: Page/Page column 17-18
[3] Patent: EP2526945, 2012, A1, . Location in patent: Page/Page column 66
[4] Patent: WO2009/66917, 2009, A2, . Location in patent: Page/Page column 17-18
[5] Patent: EP1477482, 2004, A1, . Location in patent: Page 30
[6] Patent: EP1630157, 2006, A1, . Location in patent: Page/Page column 55
[7] Patent: WO2004/52841, 2004, A1, . Location in patent: Page 87
[8] Patent: EP1445249, 2004, A1, . Location in patent: Page 114
[9] Patent: WO2006/63578, 2006, A2, . Location in patent: Page/Page column 24
[10] Patent: US2013/244958, 2013, A1, . Location in patent: Paragraph 0123
  • 19
  • [ 1631-26-1 ]
  • [ 50893-53-3 ]
  • [ 7689-50-1 ]
  • [ 86732-22-1 ]
Reference: [1] Patent: US6355641, 2002, B1, . Location in patent: Page column 39
  • 20
  • [ 50893-53-3 ]
  • [ 75-07-0 ]
  • [ 50594-97-3 ]
Reference: [1] Synthesis, 1988, # 5, p. 407 - 410
  • 21
  • [ 100-02-7 ]
  • [ 50893-53-3 ]
  • [ 101623-69-2 ]
YieldReaction ConditionsOperation in experiment
97% With pyridine In dichloromethane at 0 - 20℃; for 1.5 h; To an ice cold reaction mixture containing p-nitrophenol (1.39 g, 10 mmol) and pyridine (0.81 g, 10 mmol) in dichloromethane (60 mL) was added 1-chloroethyl chloroformate (1.2 mL, 11 mmol). The mixture was stirred at 0° C. for 30 min and then at room temperature for 1 hour. After removing the solvent under reduced pressure, the residue was dissolved in ether, washed with water, 10percent citric acid and water. The ether layer was dried over Na2SO4 and evaporated under reduced pressure to give 2.4 g (97percent) of the title compound (57) as an off-white solid. 1H NMR (CDCl3): 1.93 (d, 3H), 6.55 (q, 1H), 7.42 (d, 2H), 8.28 (d, 2H).
92% With pyridine In dichloromethane at 0 - 20℃; for 6 h; Example 3: 1-iodoethyl 4-nitrophenyl carbonateSTEP A: 1-chloroethyl 4-nitrophenyl carbonate.To a solution of 4-nitrophenol (3.0 g, 21.6 mmol) and pyridine (1.9 mL, 24 mmol) in CH2C12 (48 mL) cooled to 0°C, 1-chloroethyl chloroformate (2.3 mL, 21.6 mmol) was added. The reaction was stirred at room temperature for 5-6 hours, then washed with NaH2PC>4 (5percent) and brine, dried over Na2SC>4 and concentrated affording the title compound (4.88 g, 92percent) as a pale yellow solid.
92% at 0 - 20℃; STEP A: 1-chloroethyl 4-nitrophenyl carbonateTo a solution of 4-nitrophenol (3.0 g, 21.6 mmol) and pyridine (1.9 mL, 24 mmol) cooled to 0°C, 1-chloroethyl chloroformate (2.3 mL, 21.6 mmol) was added. The reaction was stirred at room temperature for 5-6 hours, then washed with Na3/4P04 (5percent) and brine, dried over Na2 S C>4 and concentrated affording the title compound (4.88 g, 92percent) as a pale yellow solid.1H-NMR (CDC13) : 8.32 (2H,m); 7.44 (2H,m); 6.52 ( 1H, q, J=5.8 Hz); 1.94 (3H, d, J=5.5Hz) .
88% With pyridine In chloroform at 0 - 20℃; Step 1:
1-Chloroethylchloroformate (7.8 ml, 72 mmol, 1 eq.) was added to an ice-cold solution of p-nitrophenol (10 g, 72 mmol) in chloroform (100 mL), followed by drop wise addition of pyridine (8.8 ml, 108 mmol, 1.5 eq.) over a period of 20 min.
The mixture was stirred in the ice-cold bath for 15 min, and then at room temperature overnight.
The reaction mixture was sequentially washed with water, 1 N hydrochloric acid, water, 1 N sodium hydroxide, water, and brine.
The organic phase was dried over Na2SO4, and concentrated to give yellow oil which, upon standing, crystallized to afford the corresponding chloroethyl carbonate (15.5 g, 88percent).
85% With triethylamine In dichloromethane at 0 - 20℃; To an ice-cold solution of 4-nitrophenol (2.0 g, 15 mmol) and triethylamine (1.6 g, 16 mmol) in dichloromethane (20 ml) was added a solution of 1-chloroethyl chloroformate (2.1 g, 19 mmol) in dichloromethane, and the mixture was stirred for 15 min at 0 °C and then overnight at room temperature. The mixture was extracted with dichloromethane (50 ml), washed successively with water (50 ml), 0.5 N sodium hydroxide (50 ml), saturated aqueous sodium chloride solution (50 ml), and water (3 x 50 ml), and dried over Na2SO4. The dichloromethane solution was filtered and evaporated under reduced pressure, and the residue was purified by silica gel column chromatography with chloroform (100percent) as eluent to furnish pure 1-chloroethyl 4- nitrophenyl carbonate, as a white solid in 85percent yield.
1.67 g
Stage #1: With pyridine In dichloromethane at 0 - 4℃; for 0.166667 h;
Stage #2: at 20℃;
First, place a 4-nitro phenol 10g on 250ml flask and dissolved in 100ml of methylene chloride. The reaction was cooled to 0 ~ 4 and slowly added 5.92ml of pyridine. After stirring for 10 minutes and added to 1-chloroethyl chloroformate 8.81ml slowly. Warm to room temperature and then stirred for 30 minutes and stirred overnight. After distillation under reduced pressure and the residue was dissolved in diethyl ether and washed with water, 10wtpercent citric acid solution, water order. Distilled under reduced pressure after dried over anhydrous sodium sulfate phenyl 1-chloro-ethyl-4-nitro-carbonate to give the 1.67g.

Reference: [1] Journal of Antibiotics, 1999, vol. 52, # 7, p. 643 - 648
[2] Patent: US2006/229361, 2006, A1, . Location in patent: Page/Page column 37
[3] Journal of Pharmacology and Experimental Therapeutics, 2016, vol. 357, # 2, p. 240 - 247
[4] Journal of Medicinal Chemistry, 1988, vol. 31, # 2, p. 318 - 322
[5] Patent: WO2011/92065, 2011, A1, . Location in patent: Page/Page column 60
[6] Patent: WO2011/101245, 2011, A1, . Location in patent: Page/Page column 38
[7] Bioorganic and Medicinal Chemistry Letters, 1997, vol. 7, # 14, p. 1811 - 1816
[8] Patent: US2008/146642, 2008, A1, . Location in patent: Page/Page column 45
[9] Patent: WO2007/27248, 2007, A2, . Location in patent: Page/Page column 22
[10] Bioorganic and Medicinal Chemistry, 2001, vol. 9, # 1, p. 191 - 198
[11] Journal of Medicinal Chemistry, 2016, vol. 59, # 14, p. 6658 - 6670
[12] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 21, p. 7593 - 7603
[13] Journal of Medicinal Chemistry, 1999, vol. 42, # 19, p. 3994 - 4000
[14] Patent: US2002/19437, 2002, A1,
[15] Patent: US5602118, 1997, A,
[16] Patent: US2004/138108, 2004, A1,
[17] Patent: WO2008/79839, 2008, A1, . Location in patent: Page/Page column 40
[18] Patent: WO2010/63002, 2010, A2, . Location in patent: Page/Page column 26
[19] Patent: KR2015/106357, 2015, A, . Location in patent: Paragraph 0171-0175
[20] Patent: WO2018/81513, 2018, A1, . Location in patent: Page/Page column 112
  • 22
  • [ 50893-53-3 ]
  • [ 24424-99-5 ]
  • [ 40110-55-2 ]
  • [ 135716-08-4 ]
Reference: [1] Patent: US6518423, 2003, B1,
  • 23
  • [ 50893-53-3 ]
  • [ 161357-89-7 ]
Reference: [1] Patent: US2012/196824, 2012, A1,
  • 24
  • [ 50893-53-3 ]
  • [ 24424-99-5 ]
  • [ 80845-58-5 ]
  • [ 184368-74-9 ]
Reference: [1] Patent: US6518423, 2003, B1,
  • 25
  • [ 50893-53-3 ]
  • [ 24424-99-5 ]
  • [ 532-24-1 ]
  • [ 185099-67-6 ]
YieldReaction ConditionsOperation in experiment
73%
Stage #1: at 80℃; for 5 h;
Stage #2: at 20 - 75℃; for 1.5 h;
3-Oxo-8-aza-bicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester. A mixture of 8-methyl-8-aza-bicyclo[3.2.1]octan-3-one (50.5 g, 359 mmol) and 1- chloroethyl chloroformate (117 mL, 1.08 mol) in CH2ClCH2Cl (500 mL) was heated to 80 0C for 5 h. The mixture was allowed to cool to rt, and the solvents were removed under reduced pressure. The residue was dried under high vacuum for 3 h, and was added in portions to MeOH (250 mL) over 30 min. The mixture was stirred at 75 0C for 1 h, and allowed to cool to rt. The solvents were removed under reduced pressure. The residue was diluted with Et2O (250 mL), and the mixture was sonicated for 15 min. The mixture was then stirred for 30 min, and filtered. The precipitate was washed with Et2O (125 mL), and dried under high vacuum. The residue was diluted with dioxane (400 mL), and the mixture was cooled to 0 0C. Aq. IM NaOH (400 mL) was added. BoC2O (82.3 g, 377 mmol) was added, and the mixture was stirred overnight while warming up to rt. The mixture was extracted with Et2O (2x). The combined org. extracts were dried over MgSO4, filtered, and the solvents were removed under reduced pressure. Purification of the crude by FC (EtO Ac/heptane 3:7) yielded the title compound (59.0 g, 73percent). LC-MS: tR = 0.83 min.
Reference: [1] Patent: WO2007/88514, 2007, A1, . Location in patent: Page/Page column 75-76
  • 26
  • [ 50893-53-3 ]
  • [ 13734-36-6 ]
  • [ 32399-12-5 ]
  • [ 338990-31-1 ]
YieldReaction ConditionsOperation in experiment
72.9%
Stage #1: With diisopropylamine In dichloromethane at -13℃; for 2 h;
Stage #2: With dmap; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at -7℃; for 2.16667 h;
h) Preparation of [N-methyl-N-3-((tert-butoxycarbonylmethylamino)acetoxymethyl)pyridin-2-yl]carbamic acid 1-chloro-ethyl ester; [00317] 2-(N-methylamino)-3-hydroxymethylpyridine (22 g,0.159 mol) and diisopropylamine (36.1 mL, 0.207 mol, 1.3 eq.) were dissolved in dichloromethane(1L) and cooled in ethanol-ice bath(ca-13° C.). 1-Chloroethyl chloroformate(17.5 mL, 0.161 mol, 1.01 eq.) was added dropwise over a period of 1 h and the mixture was stirred for 1 h.Boc-sarcosine(39.2 g, 0.207 mol, 1.3 eq.) was added to the stirring mixture and WSC(39.7 g, 0.207 mol. 1.3 eq.) was added portionwise over a period of 10 min. To the mixture was added DMAP(5.8 g, 0.047 mol, 0.3 eq.) and the mixture was stirred for 2 h at -7° C. The reaction mixture was concentrated at 25° C. and the residue was dissolved in diethylether(1L). The solution was transferred to the separate funnel and washed with 0.1N-HCl(500 mL.x.3), water (500 mL), NaHCO3 aq.(500 mL) and brine(500 mL.x.2) successively, dried over MgSO4 and concentrated under reduced pressure. The obtained residue(48.2 g, ca 72.9percent yield) was used for the next step without purification. 1H-NMR (270 MHz,CDCl3): δ 1.42 (9H, d, J=24.1), 1.57 (1.5H, br.s), 1.88 (1.5H, br.s), 2.94 (3H, s), 3.37 (3H, s), 4.00 (2H, d, J=21.1), 5.18 (2H, d, J=13.5), 6.58 (1H, q, J=5.45, 11.0), 7.30 (1H, s), 7.82 (1H, d, J=6.9), 8.47 (1H, s); FAB-MS: m/z 416 (M+H)+.
64%
Stage #1: With N-ethyl-N,N-diisopropylamine In dichloromethane at -13℃; for 1 h;
Stage #2: With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at -7℃; for 2 h;
2-(N-methylamino)-3-hydroxymethylpyridine (2.2 g, 16 mmol) and diisopropylamine (3.6 mL, 20.7 mmol) in 50 mL of methylene chloride, cooled to -13 ° C, and 10 mL of 1.75 mL (16.1 mmol) 1-chloroethyl chloroformate in dichloromethane solution was added and the reaction mixture was stirred for 1 h. To the stirred mixture was added 3. 9 g (20.7 mmol) of Boc-sarcosine,Then, 3. 9 g (20.7 mmol) of EDCI and 0. 58 g (4.7 mmol) of DMAP were added slowly and the mixture was stirred at -7 ° C for 2 h. The reaction was concentrated at 25 ° C. The residue was dissolved in 50 mL of ether and washed with 0.1 N HC1 (50 mL * 3), water (50 mL), and aqueous sodium hydrogencarbonate solution (50 mL) and brine (50 mL * 2), dried over anhydrous sodium sulfate and concentrated under reduced pressure to give an oily solid 4. 6 g, yield 64percent. The purity was 48.90percent by HPLC.
Reference: [1] Patent: US6812238, 2004, B1, . Location in patent: Page/Page column 21-22; 36
[2] Patent: CN106032356, 2016, A, . Location in patent: Paragraph 0042; 0043
  • 27
  • [ 50893-53-3 ]
  • [ 338990-31-1 ]
YieldReaction ConditionsOperation in experiment
80% With N-ethyl-N,N-diisopropylamine In dichloromethane at 40℃; for 2 h; A mixture of 30. 9 g (0.10 mmol) of 3-((tert-butoxycarbonyl-N-methylamino)acetoxymethyl)-2-methylaminopyridine and(0.13 mol) of diisopropylethylamine was dissolved in 60 mL of dichloromethane, and 18.6 g (0.13 mol) of 1-chloroethyl chloroformate was added dropwise at room temperature. The mixture was warmed to 40 ° C, stirred for 2 h, The methylene chloride layer was washed with aqueous ammonium chloride solution, dried and concentrated to give a yellow oil which was dissolved in 5 volumes of ethyl acetate at -5 to 0 ° C and a solution of leq hydrogen chloride in acetic acid Ester solution, stirred for 30 minutes, and filtered to obtain 33.3 g of a white solid. Yield 80percent. The purity was 86.13percent by HPLC.
Reference: [1] Patent: CN106032356, 2016, A, . Location in patent: Paragraph 0033; 0034
  • 28
  • [ 50893-53-3 ]
  • [ 1170994-04-3 ]
  • [ 923590-95-8 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 19, p. 7804 - 7815
Same Skeleton Products
Historical Records